ParkinsonCanadaV1, France, Analysis, bibRecord, 000319

Attentional deficits in Parkinson's disease : Partial reversibility with naphtoxazine (SDZ NVI-085), a selective noradrenergic α1 agonist

Identifieur interne : 000319 ( France/Analysis ); précédent : 000318; suivant : 000320

Attentional deficits in Parkinson's disease : Partial reversibility with naphtoxazine (SDZ NVI-085), a selective noradrenergic α1 agonist

Auteurs : M.-A. Bedard [Canada] ; F. El Massioui [France] ; C. Malapani [France] ; B. Dubois [France] ; B. Pillon [France] ; B. Renault [France] ; Yves Agid [France]

Source :

Clinical neuropharmacology [ 0362-5664 ] ; 1998.

RBID : Pascal:98-0274247

Descripteurs français

Pascal (Inist)
- Parkinson maladie, Lobe frontal syndrome, Trouble attention, Chimiothérapie, Traitement, Agoniste, Récepteur α1-adrénergique, Noradrénaline, Neurotransmetteur, Test neuropsychologique, Potentiel évoqué cognitif, Stimulus acoustique, Electrodiagnostic, Homme, Naphtoxazine.
Wicri :
- topic : Homme.

English descriptors

KwdEn :
- Acoustic stimulus, Agonist, Attentional disorder, Chemotherapy, Electrodiagnosis, Event evoked potential, Frontal lobe syndrome, Human, Neuropsychological test, Neurotransmitter, Norepinephrine, Parkinson disease, Treatment, α1-Adrenergic receptor.

Affiliations:

Links toward previous steps (curation, corpus...)

to stream PascalFrancis, to step Corpus: 000E20
to stream PascalFrancis, to step Curation: 001103
to stream PascalFrancis, to step Checkpoint: 000D25
to stream Main, to step Merge: 004075
to stream Main, to step Curation: 003A51
to stream Main, to step Exploration: 003A51
to stream France, to step Extraction: 000319

Links to Exploration step

Pascal:98-0274247

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Attentional deficits in Parkinson's disease : Partial reversibility with naphtoxazine (SDZ NVI-085), a selective noradrenergic α<sub>1</sub>
 agonist</title>
<author><name sortKey="Bedard, M A" sort="Bedard, M A" uniqKey="Bedard M" first="M.-A." last="Bedard">M.-A. Bedard</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>CHUM, Notre Dame Pavillon, and UQAM</s1>
<s2>Montréal</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<placeName><settlement type="city">Montréal</settlement>
<region type="state">Québec</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="El Massioui, F" sort="El Massioui, F" uniqKey="El Massioui F" first="F." last="El Massioui">F. El Massioui</name>
<affiliation wicri:level="3"><inist:fA14 i1="02"><s1>CNRS-URA 654, Salpêtrière Hospital</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Malapani, C" sort="Malapani, C" uniqKey="Malapani C" first="C." last="Malapani">C. Malapani</name>
<affiliation wicri:level="3"><inist:fA14 i1="03"><s1>INSERM U-289</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Dubois, B" sort="Dubois, B" uniqKey="Dubois B" first="B." last="Dubois">B. Dubois</name>
<affiliation wicri:level="3"><inist:fA14 i1="03"><s1>INSERM U-289</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Pillon, B" sort="Pillon, B" uniqKey="Pillon B" first="B." last="Pillon">B. Pillon</name>
<affiliation wicri:level="3"><inist:fA14 i1="03"><s1>INSERM U-289</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Renault, B" sort="Renault, B" uniqKey="Renault B" first="B." last="Renault">B. Renault</name>
<affiliation wicri:level="3"><inist:fA14 i1="02"><s1>CNRS-URA 654, Salpêtrière Hospital</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Agid, Y" sort="Agid, Y" uniqKey="Agid Y" first="Y." last="Agid">Yves Agid</name>
<affiliation wicri:level="3"><inist:fA14 i1="03"><s1>INSERM U-289</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
<placeName><settlement type="city">Paris</settlement>
<region type="region" nuts="2">Île-de-France</region>
</placeName>
<orgName type="hospital" n="4">Hôpital de la Salpêtrière</orgName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">98-0274247</idno>
<date when="1998">1998</date>
<idno type="stanalyst">PASCAL 98-0274247 INIST</idno>
<idno type="RBID">Pascal:98-0274247</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000E20</idno>
<idno type="wicri:Area/PascalFrancis/Curation">001103</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000D25</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000D25</idno>
<idno type="wicri:doubleKey">0362-5664:1998:Bedard M:attentional:deficits:in</idno>
<idno type="wicri:Area/Main/Merge">004075</idno>
<idno type="wicri:Area/Main/Curation">003A51</idno>
<idno type="wicri:Area/Main/Exploration">003A51</idno>
<idno type="wicri:Area/France/Extraction">000319</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Attentional deficits in Parkinson's disease : Partial reversibility with naphtoxazine (SDZ NVI-085), a selective noradrenergic α<sub>1</sub>
 agonist</title>
<author><name sortKey="Bedard, M A" sort="Bedard, M A" uniqKey="Bedard M" first="M.-A." last="Bedard">M.-A. Bedard</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>CHUM, Notre Dame Pavillon, and UQAM</s1>
<s2>Montréal</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<placeName><settlement type="city">Montréal</settlement>
<region type="state">Québec</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="El Massioui, F" sort="El Massioui, F" uniqKey="El Massioui F" first="F." last="El Massioui">F. El Massioui</name>
<affiliation wicri:level="3"><inist:fA14 i1="02"><s1>CNRS-URA 654, Salpêtrière Hospital</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Malapani, C" sort="Malapani, C" uniqKey="Malapani C" first="C." last="Malapani">C. Malapani</name>
<affiliation wicri:level="3"><inist:fA14 i1="03"><s1>INSERM U-289</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Dubois, B" sort="Dubois, B" uniqKey="Dubois B" first="B." last="Dubois">B. Dubois</name>
<affiliation wicri:level="3"><inist:fA14 i1="03"><s1>INSERM U-289</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Pillon, B" sort="Pillon, B" uniqKey="Pillon B" first="B." last="Pillon">B. Pillon</name>
<affiliation wicri:level="3"><inist:fA14 i1="03"><s1>INSERM U-289</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Renault, B" sort="Renault, B" uniqKey="Renault B" first="B." last="Renault">B. Renault</name>
<affiliation wicri:level="3"><inist:fA14 i1="02"><s1>CNRS-URA 654, Salpêtrière Hospital</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Agid, Y" sort="Agid, Y" uniqKey="Agid Y" first="Y." last="Agid">Yves Agid</name>
<affiliation wicri:level="3"><inist:fA14 i1="03"><s1>INSERM U-289</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
<placeName><settlement type="city">Paris</settlement>
<region type="region" nuts="2">Île-de-France</region>
</placeName>
<orgName type="hospital" n="4">Hôpital de la Salpêtrière</orgName>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Clinical neuropharmacology</title>
<title level="j" type="abbreviated">Clin. neuropharmacol.</title>
<idno type="ISSN">0362-5664</idno>
<imprint><date when="1998">1998</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Clinical neuropharmacology</title>
<title level="j" type="abbreviated">Clin. neuropharmacol.</title>
<idno type="ISSN">0362-5664</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Acoustic stimulus</term>
<term>Agonist</term>
<term>Attentional disorder</term>
<term>Chemotherapy</term>
<term>Electrodiagnosis</term>
<term>Event evoked potential</term>
<term>Frontal lobe syndrome</term>
<term>Human</term>
<term>Neuropsychological test</term>
<term>Neurotransmitter</term>
<term>Norepinephrine</term>
<term>Parkinson disease</term>
<term>Treatment</term>
<term>α1-Adrenergic receptor</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Parkinson maladie</term>
<term>Lobe frontal syndrome</term>
<term>Trouble attention</term>
<term>Chimiothérapie</term>
<term>Traitement</term>
<term>Agoniste</term>
<term>Récepteur α1-adrénergique</term>
<term>Noradrénaline</term>
<term>Neurotransmetteur</term>
<term>Test neuropsychologique</term>
<term>Potentiel évoqué cognitif</term>
<term>Stimulus acoustique</term>
<term>Electrodiagnostic</term>
<term>Homme</term>
<term>Naphtoxazine</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<affiliations><list><country><li>Canada</li>
<li>France</li>
</country>
<region><li>Québec</li>
<li>Île-de-France</li>
</region>
<settlement><li>Montréal</li>
<li>Paris</li>
</settlement>
<orgName><li>Hôpital de la Salpêtrière</li>
</orgName>
</list>
<tree><country name="Canada"><region name="Québec"><name sortKey="Bedard, M A" sort="Bedard, M A" uniqKey="Bedard M" first="M.-A." last="Bedard">M.-A. Bedard</name>
</region>
</country>
<country name="France"><region name="Île-de-France"><name sortKey="El Massioui, F" sort="El Massioui, F" uniqKey="El Massioui F" first="F." last="El Massioui">F. El Massioui</name>
</region>
<name sortKey="Agid, Y" sort="Agid, Y" uniqKey="Agid Y" first="Y." last="Agid">Yves Agid</name>
<name sortKey="Dubois, B" sort="Dubois, B" uniqKey="Dubois B" first="B." last="Dubois">B. Dubois</name>
<name sortKey="Malapani, C" sort="Malapani, C" uniqKey="Malapani C" first="C." last="Malapani">C. Malapani</name>
<name sortKey="Pillon, B" sort="Pillon, B" uniqKey="Pillon B" first="B." last="Pillon">B. Pillon</name>
<name sortKey="Renault, B" sort="Renault, B" uniqKey="Renault B" first="B." last="Renault">B. Renault</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/France/Analysis

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000319 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/France/Analysis/biblio.hfd -nk 000319 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    France
   |étape=   Analysis
   |type=    RBID
   |clé=     Pascal:98-0274247
   |texte=   Attentional deficits in Parkinson's disease : Partial reversibility with naphtoxazine (SDZ NVI-085), a selective noradrenergic α1 agonist
}}

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022

	La maladie de Parkinson au Canada (serveur d'exploration)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

La maladie de Parkinson au Canada (serveur d'exploration)

Attentional deficits in Parkinson's disease : Partial reversibility with naphtoxazine (SDZ NVI-085), a selective noradrenergic α1 agonist

Attentional deficits in Parkinson's disease : Partial reversibility with naphtoxazine (SDZ NVI-085), a selective noradrenergic α1 agonist

Source :

Descripteurs français

English descriptors

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri